WallStreetZenWallStreetZen

NASDAQ: VINC
Vincerx Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VINC earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$38.2M
Current Profit Margin
0%

VINC Return on Equity

Current Company
-303.1%
Current Industry
16.9%
Current Market
28.2%
VINC's Return on Equity (-303.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VINC announces earnings.

VINC Return on Assets

Current Company
-168.4%
Current Industry
3.2%
VINC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VINC Return on Capital Employed

Current Company
-8,517.82%
Current Industry
-42.5%
VINC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VINC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VINC$0.00-$37.22M-$38.25MN/AN/A
NRBO$0.00-$16.57M-$16.58MN/AN/A
AIM$193.00k-$30.58M-$31.12M-9.10%N/A
SNSE$0.00-$29.05M-$31.92MN/AN/A
SYBX$3.21M-$68.01M-$73.22M+5.06%N/A
View Top Biotech Stocks

Vincerx Pharma Earnings & Revenue FAQ

What were VINC's earnings last quarter?

On Invalid Date, Vincerx Pharma (NASDAQ: VINC) reported Q1 2024 earnings per share (EPS) of -$0.58, up 15.94% year over year. Total Vincerx Pharma earnings for the quarter were -$12.43 million. In the same quarter last year, Vincerx Pharma's earnings per share (EPS) was -$0.69.

If you're new to stock investing, here's how to buy Vincerx Pharma stock.

What was VINC's earnings growth in the past year?

As of Q2 2024, Vincerx Pharma's earnings has grown year over year. Vincerx Pharma's earnings in the past year totalled -$38.25 million.

What was VINC's revenue last quarter?

On Invalid Date, Vincerx Pharma (NASDAQ: VINC) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Vincerx Pharma's revenue was $0.00.

What was VINC's revenue growth in the past year?

As of Q2 2024, Vincerx Pharma's revenue has grown null year over year. Vincerx Pharma's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.